gliclazide has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amighi, K; Dubois, J; Goole, J; Jabin, I; Kiss, R; Lallemand, B; Lamkami, T; Mathieu, V; Ouedraogo, M; Wauthoz, N | 1 |
1 other study(ies) available for gliclazide and Astrocytoma, Grade IV
Article | Year |
---|---|
Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Emulsions; Female; Fibroblasts; Glioblastoma; Glycyrrhetinic Acid; Humans; Mice; Particle Size; Proteasome Endopeptidase Complex | 2013 |